Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-13 | 35.0 | 80 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-13 | 40.0 | 55 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | IL-13 | 33.0 | 65 | |
RA2159 | EO1428 | 1.0 | uM | 1 | IL-13 | 23.0 | 50 | ||||
N2586 | TNF-a | 100 | ng/mL | 1 | IL-13 | 58.0 | 61 | ||||
N2586 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 1 | IL-13 | 37.5 | 56 | |
N2586 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-13 | 67.0 | 56 | |
N2586 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-13 | 50.0 | 59 | |
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-13 | 38.0 | 43 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | IL-13 | 54.0 | 55 | |
N2586 | EO1428 | 1.0 | uM | 1 | IL-13 | 45.0 | 39 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 1 | IL-13 | 46.0 | 65 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-13 | 46.5 | 76 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-13 | 33.0 | 64 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-13 | 44.0 | 54 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-13 | 35.0 | 61 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-13 | 39.0 | 64 | |
RA2159 | PI103 | 0.1 | uM | 1 | IL-13 | 25.0 | 63 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 1 | IL-13 | 62.0 | 57 | ||||
N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-13 | 44.0 | 53 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-13 | 39.0 | 53 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-13 | 52.0 | 52 | |
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-13 | 60.0 | 57 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-13 | 51.5 | 50 | |
N2586 | PI103 | 0.1 | uM | 1 | IL-13 | 34.5 | 62 |